The development process differs between reference biologic and biosimilar medicines as they have different objectives to meet. During the development of an originator/reference biologic medicine, the emphasis is on clinical studies to establish the clinical benefit of the medicine. As the objective of biosimilar development is to establish similarity with the reference product, the focus … Continue reading Differences In Development Emphasis